[A new preparation of biosporin and its effect on the intestinal microflora in dysbacterioses in newborn infants].
Biosporin, a new biological drug made on the basis of sporulating aerobic bacteria, has been studied for its effect on the intestine microflora in case of dysbacterioses and acute digestive disorders in 53 newborn children with perinatal pathology. The results obtained prove high prophylactic and therapeutic efficiency (clinical and bacteriological) of biosporin for dysbacterioses and diarrheas in the newborn children. No negative after effects were observed. The preparation not only decontaminated pathogenic microorganisms, but also promoted necessary correction bacteriotherapy.